𝗞𝗿𝗶𝘀𝘁𝗶 𝗠𝗼𝗼𝗿𝗲 𝗷𝗼𝗶𝗻𝘀 𝗩𝗮𝘅𝘅𝗶𝗻𝗼𝘃𝗮 𝗮𝘀 𝗖𝗦𝗢

Nijmegen, the Netherlands, Jan 7, 2025 – We are pleased to announce that, as per Monday January 6, 2025, Kristi Moore joins Vaxxinova as Chief Scientific Officer.
Kristi (USA) brings over 30 years of R&D experience and 26 years of industry experience in animal health research with expertise in poultry vaccines. Kristi has a proven track record in leading R&D/RA teams, in international site to site transfer of products and technologies and M&A/technology scouting.
Kristi will be a member of the Global Management Team (GMT) and International Management Team (IMT) and be responsible for the full CSO portfolio, including R&D, RA and IP/Patents, reporting to the CEO. Kristi will relocate to the Netherlands in the next months.
We are convinced that Kristi will strongly add complementary strengths to Vaxxinova and we wish her lots of success in and a warm welcome to Vaxxinova.